Publicaciones en las que colabora con Vicente Arroyo Pérez (85)

2024

  1. A robust clustering strategy for stratification unveils unique patient subgroups in acutely decompensated cirrhosis

    Journal of Translational Medicine, Vol. 22, Núm. 1

  2. Albumin reprograms the B cell transcriptional landscape and improves neutrophil antimicrobial function in patients with decompensated cirrhosis

    JHEP Reports, Vol. 6, Núm. 11

  3. Terlipressin therapy is associated with increased risk of colonisation with multidrug-resistant bacteria in patients with decompensated cirrhosis

    Alimentary Pharmacology and Therapeutics, Vol. 59, Núm. 7, pp. 877-888

2023

  1. Genetic Ancestry, Race, and Severity of Acutely Decompensated Cirrhosis in Latin America

    Gastroenterology, Vol. 165, Núm. 3, pp. 696-716

  2. Sympathetic nervous activation, mitochondrial dysfunction and outcome in acutely decompensated cirrhosis: the metabolomic prognostic models (CLIF-C MET)

    Gut, Vol. 72, Núm. 8, pp. 1581-1591

2022

  1. Albumin Lipidomics Reveals Meaningful Compositional Changes in Advanced Cirrhosis and Its Potential to Promote Inflammation Resolution

    Hepatology Communications, Vol. 6, Núm. 6, pp. 1443-1456

  2. Location and allocation: Inequity of access to liver transplantation for patients with severe acute-on-chronic liver failure in Europe

    Liver Transplantation, Vol. 28, Núm. 9, pp. 1429-1440

  3. Mitochondrial dysfunction governs immunometabolism in leukocytes of patients with acute-on-chronic liver failure

    Journal of Hepatology, Vol. 76, Núm. 1, pp. 93-106

  4. Rectal colonization by resistant bacteria increases the risk of infection by the colonizing strain in critically ill patients with cirrhosis

    Journal of Hepatology, Vol. 76, Núm. 5, pp. 1079-1089

  5. Sepsis and the liver

    Cardio-Hepatology: Connections Between Hepatic and Cardiovascular Disease (Elsevier), pp. 145-164

2021

  1. Albumin protects the liver from tumor necrosis factor α-induced immunopathology

    FASEB Journal, Vol. 35, Núm. 2

  2. Differential inflammasome activation predisposes to acute-on-chronic liver failure in human and experimental cirrhosis with and without previous decompensation

    Gut, Vol. 70, Núm. 2, pp. 379-387

  3. Liver transplantation for patients with acute-on-chronic liver failure (ACLF) in Europe: Results of the ELITA/EF-CLIF collaborative study (ECLIS)

    Journal of Hepatology, Vol. 75, Núm. 3, pp. 610-622

  4. PREDICT identifies precipitating events associated with the clinical course of acutely decompensated cirrhosis

    Journal of Hepatology, Vol. 74, Núm. 5, pp. 1097-1108

  5. Reply to: Correspondence on ‘The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiology’

    Journal of Hepatology

  6. Reply to: “Systemic inflammation and disorders of hemostasis in the AD-ACLF syndrome”

    Journal of Hepatology

  7. The systemic inflammation hypothesis: Towards a new paradigm of acute decompensation and multiorgan failure in cirrhosis

    Journal of Hepatology, Vol. 74, Núm. 3, pp. 670-685

  8. Untargeted lipidomics uncovers lipid signatures that distinguish severe from moderate forms of acutely decompensated cirrhosis

    Journal of Hepatology, Vol. 75, Núm. 5, pp. 1116-1127

2020

  1. Albumin in decompensated cirrhosis: New concepts and perspectives

    Gut, Vol. 69, Núm. 6, pp. 1127-1138

  2. Albumin internalizes and inhibits endosomal TLR signaling in leukocytes from patients with decompensated cirrhosis

    Science Translational Medicine, Vol. 12, Núm. 566